KO’ZNING RETINAL DEGENERATIV PATOLOGIYALARIDA ZAMONAVIY PROFILAKTIKA XUSUSIYATLARINI BAHOLASH
##article.subject##:
Qarilik makulyar degeneratsiyasi (QMD), birlamchi ochiq burchakli glaukoma (BOBG), vitamin, antioksidant moddalar, chala oksidlangan erkin radikallar, Ophthalmocomplex preparati, sog'lom ovqatlanish##article.abstract##
Qarilik makulyar degeneratsiyasi (QMD) bu bosqichma bosqich rivojlanuvchi ko'z kasalligi bo'lib, bir vaqtda xoriokapillariyalar, Brux membranasi va retinal pigment epiteliysi (RPE) ning fiziologik funksiyasi buzilib, fotoreseptor qatlamda defekt paydo bo'ladi va markaziy ko'rishning qaytarilmas yo'qotilishiga sabab bo'ladi. Birlamchi ochiq burchakli glaukoma - bu oldingi kamera burchagining ochiq bo'lishiga qaramasdan ko'z ichki susyuqligi gidrodinamikasi buzulishi va ko'ruv nervining zararlanishi bilan kechuvchi patologik jarayondir. Bu kasallikda ko'pincha ko'z ichki bosimi (KIB) oshadi va retinal qavat kompression darajasiga bog'liq holda periferik ko'rish kamayib boradi. JSST ning statistik ma'lumotlariga ko'ra BOBG keyinchalik 41% holatda QMD ning "quruq" shakli bilan asoratlanadi, ya'ni klinik amaliyotda yuqoridagi ikki patologiyaning kombinatsiyasini sezilarli miqdorda kuzatish mumkin. Birlamchi ochiq burchakli glaukoma (BOBG) va qarilik makulyar degeneratsiyasi (QMD) kabi surunkali degenerativ ko'z kasalliklarining profilaktikasi va davolash jarayonida antioksidant mikroelementlarga boy bo'lgan ozuqa mahsulotlari hamda “Ophthalmocomplex” preparatini iste'mol qilish reabilitatsion davrni qisqarishiga sabab bo'ladi. Patologik jarayonlarning (ayniqsa yallig'lanish, degeneratsiya) rivojlanish mexanizmlari turlicha, lekin ular orasida detosikatsiya natijasida antioksidant himoya tizimini buzulishi asosiy patogenetik nuqta hisoblanadi.
Библиографические ссылки
Kiselyova TN, Polunin GS, Budzinskaya MV, Lagutina YM, Vorobyova MV. Modern approaches to the treatment and prevention of yellow spot degeneration. Jurn. [Russian medical journal] 2007; 2: 78–79. (in Russia).
Seddon J. M., Ajani U. A., Sperduto R. D. Dietary carotenoids, vitamin A, C and E and advanced age-related macular degeneration: Eye Disease case-Control Study Group. JAVA 1994; 272: 1413 1420.
Evans Jr. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration// Cochrane Database Syst. Rev. 2006;19 (2): 54.
Lyle B. J., Mares-Perlman J. A., Klein B. E. et al. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am. J. Epidemiol. 1999;149 (39): 801 809.
Zeimer M., Hense H. W., Heimes B. et al. The macular pigment: short- and intermediate - term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co - antioxidants. The LUNA Study / Ophthalmologe 2009;106:29 36.
Blokhina O., Virolainen E., Fagerstedt K. V. Antioxidants, Oxidative Damage and Oxygen Deprivation Stress: a Review. Annals of Botany 2003; 91: 179 194.
Kim S. R., Nakanishi K., Itagaki Y. et al. Photooxidation of A2 PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp. Eye Res. 2006; 82 (5): 828 39.
Bressler N. M., Silva J. C., Bressler S. B. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 2005; 25:130 42.
The Age- Related Eye Disease Study Research Group. A randomized, placebocontrolled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss.
Beatty S., Koh H-H. Henson D., Bouston M. et al. Role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000;45:115 134.
